Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation
Anthony J. Turner, Natalia N. Nalivaeva
Peptides (2022) Vol. 151, pp. 170766-170766
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension
Hafiz Ahmad, Huma Khan, Shabirul Haque, et al.
Journal of the Renin-Angiotensin-Aldosterone System (2023) Vol. 2023
Open Access | Times Cited: 40
Protective neutralizing epitopes in SARS‐CoV‐2
Hejun Liu, Ian A. Wilson
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 76-92
Open Access | Times Cited: 39
Angiotensin‐converting enzymes as druggable features of psychiatric and neurodegenerative disorders
Thays Calista Santiago, Larissa Parra, João V. Nani, et al.
Journal of Neurochemistry (2023) Vol. 166, Iss. 2, pp. 138-155
Open Access | Times Cited: 18
ACE-2-like Enzymatic Activity in COVID-19 Convalescent Patients with Persistent Pulmonary Symptoms Associated with Immunoglobulin
Yufeng Song, Frances Mehl, Lyndsey M. Muehling, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Vascular actions of Ang 1-7 and Ang 1-8 through EDRFs and EDHFs in non-diabetes and diabetes mellitus
Nazar M. Shareef Mahmood, Almas M. R. Mahmud, Ismail M. Maulood
Nitric Oxide (2025) Vol. 156, pp. 9-26
Closed Access
Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis
Cosima T. Baldari, Anna Onnis, Emanuele Andreano, et al.
Trends in Immunology (2023) Vol. 44, Iss. 6, pp. 424-434
Open Access | Times Cited: 14
The evolution of small molecule enzyme activators
Louise F. Dow, Alfie M. Case, Megan P. Paustian, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 11, pp. 2206-2230
Open Access | Times Cited: 8
Cryo‐EM reveals mechanisms of angiotensin I‐converting enzyme allostery and dimerization
Lizelle Lubbe, B.T. Sewell, Jeremy Woodward, et al.
The EMBO Journal (2022) Vol. 41, Iss. 16
Open Access | Times Cited: 13
Cytoplasmic tail determines the membrane trafficking and localization of SARS-CoV-2 spike protein
Qinlin Li, Yihan Liu, Leiliang Zhang
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 12
Epigenetic Regulation of the Renin–Angiotensin–Aldosterone System in Hypertension
Yoshimichi Takeda, Masashi Demura, Takashi Yoneda, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8099-8099
Open Access | Times Cited: 2
Regulation of the renin-angiotensin-aldosterone system by cyclic nucleotides and phosphodiesterases
Stepan Gambaryan, Sanika Mohagaonkar, Viacheslav O. Nikolaev
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6
Ectoenzymes as promising cell identification structures for the high avidity targeting of polymeric nanoparticles
Melanie Walter, Felix Baumann, Kathrin Schorr, et al.
International Journal of Pharmaceutics (2023) Vol. 647, pp. 123453-123453
Closed Access | Times Cited: 5
Human ACE2 Polymorphisms from Different Human Populations Modulate SARS-CoV-2 Infection
Pan Hu, Vanessa L. Bauer, Sara L. Sawyer, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1451-1451
Open Access | Times Cited: 9
A Closer Look at ACE2 Signaling Pathway and Processing during COVID-19 Infection: Identifying Possible Targets
Pia V. Sodhi, Francoise Sidime, David Tarazona, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 13-13
Open Access | Times Cited: 7
Live to die another day: novel insights may explain the pathophysiology behind smoker’s paradox in SARS-CoV-2 infection
Konstantinos I. Papadopoulos, Alexandra Papadopoulou, Tar Choon Aw
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 11, pp. 2517-2526
Open Access | Times Cited: 3
Phenome-wide association study and precision medicine of cardiovascular diseases in the post-COVID-19 era
Qian Cao, Xin Du, Xiao‐Yan Jiang, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 12, pp. 2347-2357
Closed Access | Times Cited: 2
Development and validation of an LC-MS/MS method for the simultaneous quantitation of angiotensin (1–7), (1–8), (1–9) and (1–10) in human plasma
Justine Demeuse, Loreen Huyghebaert, William Determe, et al.
Journal of Chromatography B (2023) Vol. 1232, pp. 123943-123943
Open Access | Times Cited: 2
New Insights into the Link between SARS-CoV-2 Infection and Renal Cancer
Vittoria Rago, Sabrina Bossio, Danilo Lofaro, et al.
Life (2023) Vol. 14, Iss. 1, pp. 52-52
Open Access | Times Cited: 2
Extracellular vesicles and angiotensin-converting enzyme 2 in COVID-19 disease
Yu Liu, ROBERT J. KASPER, NATALIE J. S. CHOI
Biocell (2024) Vol. 48, Iss. 1, pp. 1-8
Open Access
Pharmacogenetics: Therapeutic regimen in hypertension
Joshua Ivan Orona Ceron, Kevin Salais Diaz, Mariela Aketzali Salazar Herrera, et al.
GSC Advanced Research and Reviews (2024) Vol. 18, Iss. 2, pp. 097-107
Open Access
The possible mechanism and research progress of ACE2 involved in cardiovascular injury caused by COVID-19: a review
Dan Luo, Mengzhe Bai, Wei Zhang, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
Patients with Gaucher disease display systemic elevation of ACE2, which is impacted by therapy status and genotype
Ahmad Fokra, Hagit Baris Feldman, Alina Kurolap, et al.
Molecular Genetics and Metabolism (2024) Vol. 143, Iss. 1-2, pp. 108534-108534
Closed Access
Phytomedical compounds as promising therapeutic agents for COVID-19 targeting angiotensin-converting enzyme 2: a review
Smail Amtaghri, Miloudia Slaoui, Mohamed Eddouks
Journal of Pharmacy and Pharmacology (2024) Vol. 76, Iss. 10, pp. 1239-1268
Closed Access
Rabbit and Human Angiotensin-Converting Enzyme-2: Structure and Electric Properties
S. Hristova, Trifon T. Popov, Alexandar M. Zhivkov
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12393-12393
Open Access
Docking heparan sulfate-based ligands as a promising inhibitor for SARS-CoV-2
Luiz F. M. A. Benicio, Érica C. M. Nascimento, João B. L. Martins
Journal of Molecular Modeling (2024) Vol. 31, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top